Stanley Liauw to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Stanley Liauw has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.153
-
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). BMC Cancer. 2019 Jun 13; 19(1):572.
Score: 0.153